25 XP   0   0   10

TG Therapeutics Inc
Buy, Hold or Sell?

Let's analyse TG Therapeutics Inc together

PenkeI guess you are interested in TG Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TG Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about TG Therapeutics Inc

I send you an email if I find something interesting about TG Therapeutics Inc.

Quick analysis of TG Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of TG Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.04
Expected worth in 1 year
$1.70
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.66
Return On Investment
4.8%

For what price can you sell your share?

Current Price per Share
$13.82
Expected price per share
$11.56 - $15.99
How sure are you?
50%

1. Valuation of TG Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$13.82

Intrinsic Value Per Share

$-8.94 - $7.37

Total Value Per Share

$-7.90 - $8.40

2. Growth of TG Therapeutics Inc (5 min.)




Is TG Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$160.5m$114.6m-$16.3m-16.6%

How much money is TG Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money$3.3m-$50.9m$54.2m1,635.3%
Net Profit Margin-188.8%-29,258.1%--

How much money comes from the company's main activities?

3. Financial Health of TG Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#288 / 1016

Most Revenue
#147 / 1016

Most Profit
#124 / 1016

Most Efficient
#631 / 1016

What can you expect buying and holding a share of TG Therapeutics Inc? (5 min.)

Welcome investor! TG Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of TG Therapeutics Inc.

What can you expect buying and holding a share of TG Therapeutics Inc?

First you should know what it really means to hold a share of TG Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of TG Therapeutics Inc is $13.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of TG Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in TG Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.04. Based on the TTM, the Book Value Change Per Share is $0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of TG Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-0.7%0.040.3%-0.30-2.1%-0.31-2.2%-0.23-1.7%
Usd Book Value Change Per Share-0.02-0.1%0.161.2%-0.29-2.1%0.040.3%0.030.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.1%0.161.2%-0.29-2.1%0.040.3%0.030.2%
Usd Price Per Share17.08-16.33-7.88-18.88-14.51-
Price to Earnings Ratio-45.74--20.81--6.61--11.77--15.92-
Price-to-Total Gains Ratio-964.91--183.58--28.37--90.35--7.49-
Price to Book Ratio16.43-50.96-13.50--28.62--9.58-
Price-to-Total Gains Ratio-964.91--183.58--28.37--90.35--7.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.82
Number of shares72
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.160.04
Usd Total Gains Per Share0.160.04
Gains per Quarter (72 shares)11.883.18
Gains per Year (72 shares)47.5212.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1048380133
20958602516
3014313403829
4019018205142
5023823006455
6028527807668
7033332608981
80380374010294
904284220115107
1004754700127120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%2.018.00.010.0%2.038.00.05.0%10.0100.00.09.1%
Book Value Change Per Share2.02.00.050.0%2.010.00.016.7%5.015.00.025.0%13.022.05.032.5%33.068.09.030.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%10.00.0100.09.1%
Total Gains per Share2.02.00.050.0%2.010.00.016.7%5.015.00.025.0%13.022.05.032.5%35.068.07.031.8%

Fundamentals of TG Therapeutics Inc

About TG Therapeutics Inc

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.

Fundamental data was last updated by Penke on 2024-04-12 19:58:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of TG Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit TG Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare TG Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -32.8% means that $-0.33 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TG Therapeutics Inc:

  • The MRQ is -32.8%. The company is making a huge loss. -2
  • The TTM is -188.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-32.8%TTM-188.8%+156.0%
TTM-188.8%YOY-29,258.1%+29,069.2%
TTM-188.8%5Y-66,633.4%+66,444.6%
5Y-66,633.4%10Y-65,432.0%-1,201.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.8%-197.2%+164.4%
TTM-188.8%-210.4%+21.6%
YOY-29,258.1%-279.3%-28,978.8%
5Y-66,633.4%-436.8%-66,196.6%
10Y-65,432.0%-599.3%-64,832.7%
1.1.2. Return on Assets

Shows how efficient TG Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare TG Therapeutics Inc to the Biotechnology industry mean.
  • -4.4% Return on Assets means that TG Therapeutics Inc generated $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TG Therapeutics Inc:

  • The MRQ is -4.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.4%TTM-2.8%-1.6%
TTM-2.8%YOY-21.2%+18.4%
TTM-2.8%5Y-22.1%+19.4%
5Y-22.1%10Y-23.8%+1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.4%-13.6%+9.2%
TTM-2.8%-12.9%+10.1%
YOY-21.2%-11.9%-9.3%
5Y-22.1%-14.2%-7.9%
10Y-23.8%-16.2%-7.6%
1.1.3. Return on Equity

Shows how efficient TG Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare TG Therapeutics Inc to the Biotechnology industry mean.
  • -9.0% Return on Equity means TG Therapeutics Inc generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TG Therapeutics Inc:

  • The MRQ is -9.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.0%TTM-2.2%-6.7%
TTM-2.2%YOY-19.6%+17.3%
TTM-2.2%5Y-33.0%+30.7%
5Y-33.0%10Y-36.6%+3.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.0%-17.0%+8.0%
TTM-2.2%-16.1%+13.9%
YOY-19.6%-15.4%-4.2%
5Y-33.0%-20.0%-13.0%
10Y-36.6%-21.1%-15.5%

1.2. Operating Efficiency of TG Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient TG Therapeutics Inc is operating .

  • Measures how much profit TG Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare TG Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -28.4% means the company generated $-0.28  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TG Therapeutics Inc:

  • The MRQ is -28.4%. The company is operating very inefficient. -2
  • The TTM is -177.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-28.4%TTM-177.8%+149.4%
TTM-177.8%YOY-28,036.2%+27,858.4%
TTM-177.8%5Y-64,935.0%+64,757.1%
5Y-64,935.0%10Y-64,520.0%-415.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.4%-286.1%+257.7%
TTM-177.8%-224.4%+46.6%
YOY-28,036.2%-288.4%-27,747.8%
5Y-64,935.0%-475.2%-64,459.8%
10Y-64,520.0%-624.7%-63,895.3%
1.2.2. Operating Ratio

Measures how efficient TG Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are $1.28 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TG Therapeutics Inc:

  • The MRQ is 1.284. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.778. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.284TTM2.778-1.494
TTM2.778YOY281.362-278.584
TTM2.7785Y1,234.522-1,231.744
5Y1,234.52210Y53,059.739-51,825.216
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2842.997-1.713
TTM2.7783.247-0.469
YOY281.3623.766+277.596
5Y1,234.5225.675+1,228.847
10Y53,059.7397.857+53,051.882

1.3. Liquidity of TG Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if TG Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.92 means the company has $5.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TG Therapeutics Inc:

  • The MRQ is 5.919. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.704. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.919TTM3.704+2.215
TTM3.704YOY4.322-0.618
TTM3.7045Y3.723-0.019
5Y3.72310Y6.010-2.287
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9193.930+1.989
TTM3.7044.251-0.547
YOY4.3225.436-1.114
5Y3.7236.045-2.322
10Y6.0106.363-0.353
1.3.2. Quick Ratio

Measures if TG Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare TG Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 7.32 means the company can pay off $7.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TG Therapeutics Inc:

  • The MRQ is 7.319. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.954. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.319TTM4.954+2.365
TTM4.954YOY5.664-0.710
TTM4.9545Y4.436+0.518
5Y4.43610Y6.941-2.505
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3193.629+3.690
TTM4.9544.065+0.889
YOY5.6645.397+0.267
5Y4.4365.993-1.557
10Y6.9416.277+0.664

1.4. Solvency of TG Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of TG Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare TG Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.51 means that TG Therapeutics Inc assets are financed with 51.3% credit (debt) and the remaining percentage (100% - 51.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TG Therapeutics Inc:

  • The MRQ is 0.513. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.673. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.513TTM0.673-0.160
TTM0.673YOY0.540+0.133
TTM0.6735Y0.576+0.098
5Y0.57610Y0.596-0.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5130.332+0.181
TTM0.6730.334+0.339
YOY0.5400.268+0.272
5Y0.5760.366+0.210
10Y0.5960.390+0.206
1.4.2. Debt to Equity Ratio

Measures if TG Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare TG Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 105.3% means that company has $1.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TG Therapeutics Inc:

  • The MRQ is 1.053. The company is able to pay all its debts with equity. +1
  • The TTM is 0.263. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.053TTM0.263+0.790
TTM0.263YOY0.487-0.223
TTM0.2635Y0.837-0.573
5Y0.83710Y0.846-0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0530.381+0.672
TTM0.2630.390-0.127
YOY0.4870.334+0.153
5Y0.8370.434+0.403
10Y0.8460.466+0.380

2. Market Valuation of TG Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings TG Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare TG Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -45.74 means the investor is paying $-45.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TG Therapeutics Inc:

  • The EOD is -37.009. Based on the earnings, the company is expensive. -2
  • The MRQ is -45.739. Based on the earnings, the company is expensive. -2
  • The TTM is -20.811. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-37.009MRQ-45.739+8.730
MRQ-45.739TTM-20.811-24.928
TTM-20.811YOY-6.607-14.204
TTM-20.8115Y-11.772-9.040
5Y-11.77210Y-15.924+4.152
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-37.009-2.315-34.694
MRQ-45.739-2.560-43.179
TTM-20.811-2.664-18.147
YOY-6.607-4.122-2.485
5Y-11.772-6.258-5.514
10Y-15.924-6.108-9.816
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TG Therapeutics Inc:

  • The EOD is -40.388. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -49.915. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.636. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-40.388MRQ-49.915+9.527
MRQ-49.915TTM-19.636-30.279
TTM-19.636YOY-8.610-11.026
TTM-19.6365Y-15.369-4.268
5Y-15.36910Y-22.668+7.300
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-40.388-3.067-37.321
MRQ-49.915-3.251-46.664
TTM-19.636-3.545-16.091
YOY-8.610-5.595-3.015
5Y-15.369-8.315-7.054
10Y-22.668-8.708-13.960
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of TG Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 16.43 means the investor is paying $16.43 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of TG Therapeutics Inc:

  • The EOD is 13.296. Based on the equity, the company is expensive. -2
  • The MRQ is 16.433. Based on the equity, the company is expensive. -2
  • The TTM is 50.956. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD13.296MRQ16.433-3.136
MRQ16.433TTM50.956-34.523
TTM50.956YOY13.496+37.460
TTM50.9565Y-28.623+79.579
5Y-28.62310Y-9.580-19.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD13.2961.905+11.391
MRQ16.4332.111+14.322
TTM50.9562.095+48.861
YOY13.4962.836+10.660
5Y-28.6233.443-32.066
10Y-9.5803.794-13.374
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of TG Therapeutics Inc.

3.1. Institutions holding TG Therapeutics Inc

Institutions are holding 59.326% of the shares of TG Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc8.8530.0051136709441997701.4829
2023-12-31BlackRock Inc6.97330.0047107681637812167.8224
2023-12-31State Street Corporation5.34490.00698253573-1564049-15.931
2023-12-31Darwin Global Management, Ltd.2.620513.5659404659840465980
2023-12-31Pictet Asset Manangement SA2.19220.063833852452564842312.632
2023-12-31Goldman Sachs Group Inc2.13680.00513299674160872495.1373
2023-12-31Wellington Management Company LLP2.03330.013139764432901.398
2023-12-31Geode Capital Management, LLC2.00530.005530966461628205.5497
2023-12-31Millennium Management LLC1.89660.0216292878891235745.2461
2023-12-31Opaleye Management Inc1.434410.06221500032500017.1958
2023-12-31Paradigm Biocapital Advisors LP1.40621.73642171419-1447596-39.9997
2023-12-31Susquehanna International Group, LLP1.26190.0063194865757089641.4365
2023-12-31Woodline Partners LP1.14520.3285176843416162951062.3805
2023-12-31683 Capital Management LLC1.08472.3432167500032500024.0741
2023-09-30VOLORIDGE INVESTMENT MANAGEMENT, LLC1.04420.06651612534958954146.7233
2023-12-31FMR Inc1.02290.0021157951165067370.0524
2023-12-31Morgan Stanley - Brokerage Accounts0.96460.00221489483-387197-20.632
2023-09-30Schonfeld Strategic Advisors LLC0.88550.08891367400850507164.5422
2023-12-31Northern Trust Corp0.87480.00421350935-7063-0.5201
2023-12-31Nuveen Asset Management, LLC0.87470.00741350721968611253.4901
Total 46.05528.334371118489+13179648+18.5%

3.2. Funds holding TG Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29SPDR® S&P Biotech ETF3.47611.167353678831002631.9034
2024-02-29Vanguard Total Stock Mkt Idx Inv2.75350.00474251979-11162-0.2618
2024-02-29Vanguard Small Cap Index2.27450.0433512326324340.932
2024-02-29iShares Russell 2000 ETF2.17270.09263355050-548-0.0163
2023-12-31Vanguard Health Care Inv1.98570.1128306630400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.36370.0355210582615530.0738
2024-02-29Vanguard Small Cap Growth Index Inv1.27660.09731971408327431.6889
2023-12-31Pictet-Biotech P USD1.16851.951118044291375897321.0722
2024-01-31Fidelity Select Biotechnology0.97570.5304150672000
2023-12-31Fidelity Small Cap Index0.89370.09271380030315032.3361
2023-12-31Pictet-Global Megatrend Sel I USD0.81880.1721264446992897365.6419
2024-02-29iShares Russell 2000 Growth ETF0.7890.18481218316-1417-0.1162
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.53930.0343832825160001.9588
2024-01-31Fidelity Extended Market Index0.51690.0362798193131361.6733
2024-02-29Schwab US Small-Cap ETF™0.43340.071966918500
2024-01-31CREF Stock R10.39570.008461111000
2024-02-29Invesco Biotechnology & Genome ETF0.34463.46365321076640.1249
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.33170.093451218200
2024-02-29Vanguard Russell 2000 ETF0.32650.091504184395168.5041
2024-02-29Vanguard Health Care ETF0.31840.040649164660911.2544
Total 23.1558.323635756149+2629570+7.4%

3.3. Insider Transactions

Insiders are holding 9.077% of the shares of TG Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-12Laurence N CharneySELL2200015.97
2024-01-05Laurence N CharneySELL1750019.03
2024-01-03Sean A PowerSELL4786716.91
2023-08-11Michael S WeissBUY10000010.13
2023-06-23Sagar LonialSELL3485423.37
2023-06-02Sean A PowerSELL7364726.7

4. Summary

4.1. Key Performance Indicators

The key performance indicators of TG Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0180.165-111%-0.289+1533%0.044-140%0.026-168%
Book Value Per Share--1.0390.634+64%0.742+40%1.022+2%0.639+63%
Current Ratio--5.9193.704+60%4.322+37%3.723+59%6.010-2%
Debt To Asset Ratio--0.5130.673-24%0.540-5%0.576-11%0.596-14%
Debt To Equity Ratio--1.0530.263+300%0.487+116%0.837+26%0.846+24%
Dividend Per Share----0%-0%-0%-0%
Eps---0.0930.038-348%-0.296+217%-0.311+233%-0.235+151%
Free Cash Flow Per Share---0.086-0.052-39%-0.285+233%-0.276+223%-0.197+130%
Free Cash Flow To Equity Per Share---0.0860.066-230%-0.286+234%0.047-282%0.028-410%
Gross Profit Margin--1.2041.031+17%1.104+9%1.040+16%1.056+14%
Intrinsic Value_10Y_max--7.365--------
Intrinsic Value_10Y_min---8.943--------
Intrinsic Value_1Y_max---0.568--------
Intrinsic Value_1Y_min---1.063--------
Intrinsic Value_3Y_max---0.711--------
Intrinsic Value_3Y_min---3.068--------
Intrinsic Value_5Y_max--0.346--------
Intrinsic Value_5Y_min---4.920--------
Market Cap2134098109.440-24%2637510543.3602524726881.490+4%1216451364.480+117%2916113350.634-10%2240392026.037+18%
Net Profit Margin---0.328-1.888+476%-292.581+89142%-666.334+203142%-654.320+199477%
Operating Margin---0.284-1.778+526%-280.362+98641%-649.350+228595%-645.200+227133%
Operating Ratio--1.2842.778-54%281.362-100%1234.522-100%53059.739-100%
Pb Ratio13.296-24%16.43350.956-68%13.496+22%-28.623+274%-9.580+158%
Pe Ratio-37.009+19%-45.739-20.811-55%-6.607-86%-11.772-74%-15.924-65%
Price Per Share13.820-24%17.08016.330+5%7.878+117%18.880-10%14.506+18%
Price To Free Cash Flow Ratio-40.388+19%-49.915-19.636-61%-8.610-83%-15.369-69%-22.668-55%
Price To Total Gains Ratio-780.739+19%-964.908-183.583-81%-28.372-97%-90.345-91%-7.488-99%
Quick Ratio--7.3194.954+48%5.664+29%4.436+65%6.941+5%
Return On Assets---0.044-0.028-37%-0.212+385%-0.221+406%-0.238+445%
Return On Equity---0.090-0.022-75%-0.196+118%-0.330+267%-0.366+307%
Total Gains Per Share---0.0180.165-111%-0.289+1533%0.044-140%0.026-168%
Usd Book Value--160502000.00098289250.000+63%114622250.000+40%157844800.000+2%98681718.550+63%
Usd Book Value Change Per Share---0.0180.165-111%-0.289+1533%0.044-140%0.026-168%
Usd Book Value Per Share--1.0390.634+64%0.742+40%1.022+2%0.639+63%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.0930.038-348%-0.296+217%-0.311+233%-0.235+151%
Usd Free Cash Flow---13210000.000-7853250.000-41%-44046000.000+233%-42571650.000+222%-30398946.375+130%
Usd Free Cash Flow Per Share---0.086-0.052-39%-0.285+233%-0.276+223%-0.197+130%
Usd Free Cash Flow To Equity Per Share---0.0860.066-230%-0.286+234%0.047-282%0.028-410%
Usd Market Cap2134098109.440-24%2637510543.3602524726881.490+4%1216451364.480+117%2916113350.634-10%2240392026.037+18%
Usd Price Per Share13.820-24%17.08016.330+5%7.878+117%18.880-10%14.506+18%
Usd Profit---14416000.0003319000.000-534%-50957500.000+253%-49545200.000+244%-36996120.725+157%
Usd Revenue--43971000.00058415750.000-25%696000.000+6218%12172000.000+261%6105038.100+620%
Usd Total Gains Per Share---0.0180.165-111%-0.289+1533%0.044-140%0.026-168%
 EOD+3 -5MRQTTM+16 -18YOY+30 -45Y+22 -1210Y+23 -11

4.2. Fundamental Score

Let's check the fundamental score of TG Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-37.009
Price to Book Ratio (EOD)Between0-113.296
Net Profit Margin (MRQ)Greater than0-0.328
Operating Margin (MRQ)Greater than0-0.284
Quick Ratio (MRQ)Greater than17.319
Current Ratio (MRQ)Greater than15.919
Debt to Asset Ratio (MRQ)Less than10.513
Debt to Equity Ratio (MRQ)Less than11.053
Return on Equity (MRQ)Greater than0.15-0.090
Return on Assets (MRQ)Greater than0.05-0.044
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of TG Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.594
Ma 20Greater thanMa 5014.814
Ma 50Greater thanMa 10015.157
Ma 100Greater thanMa 20015.681
OpenGreater thanClose14.060
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Stockholder Equity -1,527,033-39,232-1,566,265-47,610-1,613,875113,930-1,499,9451,660,447160,502
Net Debt  -19,244-30,600-49,844-35,848-85,692-132,466-218,158236,02017,862
Other Stockholders Equity  -146-3-149-2-1510-1511,674,8631,674,712
Liabilities and Stockholders Equity  -1,392,048-4,292-1,396,340-37,134-1,433,47499,827-1,333,6471,663,234329,587



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets329,587
Total Liabilities169,085
Total Stockholder Equity160,502
 As reported
Total Liabilities 169,085
Total Stockholder Equity+ 160,502
Total Assets = 329,587

Assets

Total Assets329,587
Total Current Assets317,943
Long-term Assets11,644
Total Current Assets
Cash And Cash Equivalents 92,933
Short-term Investments 124,575
Net Receivables 51,093
Inventory 39,823
Other Current Assets 9,519
Total Current Assets  (as reported)317,943
Total Current Assets  (calculated)317,943
+/-0
Long-term Assets
Property Plant Equipment 8,145
Goodwill 799
Long-term Assets Other 1,415
Long-term Assets  (as reported)11,644
Long-term Assets  (calculated)10,359
+/- 1,285

Liabilities & Shareholders' Equity

Total Current Liabilities53,720
Long-term Liabilities115,365
Total Stockholder Equity160,502
Total Current Liabilities
Short-term Debt 1,446
Accounts payable 38,471
Other Current Liabilities 13,503
Total Current Liabilities  (as reported)53,720
Total Current Liabilities  (calculated)53,420
+/- 300
Long-term Liabilities
Long term Debt 100,118
Capital Lease Obligations 10,677
Long-term Liabilities  (as reported)115,365
Long-term Liabilities  (calculated)110,795
+/- 4,570
Total Stockholder Equity
Common Stock151
Retained Earnings -1,514,361
Other Stockholders Equity 1,674,712
Total Stockholder Equity (as reported)160,502
Total Stockholder Equity (calculated)160,502
+/-0
Other
Capital Stock151
Cash and Short Term Investments 217,508
Common Stock Shares Outstanding 143,093
Current Deferred Revenue300
Liabilities and Stockholders Equity 329,587
Net Debt 17,862
Net Invested Capital 260,620
Net Working Capital 264,223
Property Plant and Equipment Gross 9,560
Short Long Term Debt Total 110,795



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-31
> Total Assets 
0
2,900
3,500
2,400
1,600
2,500
10,200
8,800
7,400
8,800
7,700
6,500
5,300
4,700
4,200
4,000
3,847
2,677
3,087
3,177
3,177
1,230
615
1,758
1,758
1,058
548
251
251
3,604
529
7,799
9,958
8,948
7,626
5,650
4,391
2,599
13,073
11,206
9,275
7,688
5,316
3,448
3,448
5,277
2,358
981
1,487
973
205
1,249
1,562
1,140
683
366
20,082
19,594
19,035
18,636
18,654
18,361
18,064
15,907
27,074
26,530
25,231
22,074
21,387
17,859
54,299
48,112
58,174
56,302
77,544
86,747
117,269
123,605
127,407
113,473
100,063
94,798
75,687
54,782
123,256
101,198
101,782
97,382
120,994
140,715
114,374
83,616
117,538
106,585
93,327
163,014
101,849
294,621
273,856
625,642
548,699
481,400
409,687
379,629
303,028
251,666
217,891
193,572
197,358
220,854
331,067
329,587
329,587331,067220,854197,358193,572217,891251,666303,028379,629409,687481,400548,699625,642273,856294,621101,849163,01493,327106,585117,53883,616114,374140,715120,99497,382101,782101,198123,25654,78275,68794,798100,063113,473127,407123,605117,26986,74777,54456,30258,17448,11254,29917,85921,38722,07425,23126,53027,07415,90718,06418,36118,65418,63619,03519,59420,0823666831,1401,5621,2492059731,4879812,3585,2773,4483,4485,3167,6889,27511,20613,0732,5994,3915,6507,6268,9489,9587,7995293,6042512515481,0581,7581,7586151,2303,1773,1773,0872,6773,8474,0004,2004,7005,3006,5007,7008,8007,4008,80010,2002,5001,6002,4003,5002,9000
   > Total Current Assets 
0
2,800
3,300
2,300
1,500
2,400
9,900
8,500
7,100
8,500
7,400
6,300
5,300
4,500
4,000
3,800
3,472
2,465
2,775
2,879
2,879
1,040
468
1,630
1,630
952
457
175
175
512
448
7,791
9,919
8,893
7,432
5,460
4,066
2,413
12,899
11,029
9,104
7,527
5,168
3,294
3,294
5,143
2,235
866
1,367
712
111
874
798
525
240
264
2,286
1,826
1,268
869
902
609
313
9,836
21,003
20,457
19,158
18,476
17,789
14,169
50,613
42,303
56,288
49,287
76,666
85,215
115,738
103,727
104,730
86,873
70,577
69,552
71,332
50,864
118,964
97,044
97,661
93,317
116,958
136,038
109,737
79,031
105,058
94,441
80,355
149,151
88,016
280,938
260,335
611,740
535,013
455,068
371,779
330,965
242,216
202,560
182,922
168,274
184,783
144,905
229,159
317,943
317,943229,159144,905184,783168,274182,922202,560242,216330,965371,779455,068535,013611,740260,335280,93888,016149,15180,35594,441105,05879,031109,737136,038116,95893,31797,66197,044118,96450,86471,33269,55270,57786,873104,730103,727115,73885,21576,66649,28756,28842,30350,61314,16917,78918,47619,15820,45721,0039,8363136099028691,2681,8262,2862642405257988741117121,3678662,2355,1433,2943,2945,1687,5279,10411,02912,8992,4134,0665,4607,4328,8939,9197,7914485121751754579521,6301,6304681,0402,8792,8792,7752,4653,4723,8004,0004,5005,3006,3007,4008,5007,1008,5009,9002,4001,5002,3003,3002,8000
       Cash And Cash Equivalents 
0
2,800
3,200
2,300
1,400
2,300
9,900
8,500
7,000
8,300
7,000
5,800
5,000
4,100
3,700
3,500
3,115
1,606
1,700
2,664
2,664
1,030
441
1,592
1,592
445
376
116
116
478
102
7,414
9,543
8,866
7,409
906
545
890
11,869
9,826
8,532
6,045
3,913
3,029
3,029
4,791
2,033
650
1,133
576
36
106
230
295
154
18
2,017
1,572
1,076
479
591
493
212
9,748
20,924
20,367
17,374
16,456
15,188
13,417
50,183
40,485
49,596
37,078
53,226
55,714
86,004
60,300
65,462
55,061
36,478
28,578
29,157
25,031
95,638
77,602
91,842
56,718
82,896
105,672
70,718
41,958
64,349
57,228
44,675
112,637
52,051
260,512
254,154
553,439
471,514
401,707
326,512
298,887
185,676
147,073
109,860
102,304
61,469
97,009
229,159
92,933
92,933229,15997,00961,469102,304109,860147,073185,676298,887326,512401,707471,514553,439254,154260,51252,051112,63744,67557,22864,34941,95870,718105,67282,89656,71891,84277,60295,63825,03129,15728,57836,47855,06165,46260,30086,00455,71453,22637,07849,59640,48550,18313,41715,18816,45617,37420,36720,9249,7482124935914791,0761,5722,01718154295230106365761,1336502,0334,7913,0293,0293,9136,0458,5329,82611,8698905459067,4098,8669,5437,4141024781161163764451,5921,5924411,0302,6642,6641,7001,6063,1153,5003,7004,1005,0005,8007,0008,3007,0008,5009,9002,3001,4002,3003,2002,8000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
319
352
361
0
0
4,514
3,521
1,506
1,010
1,008
509
506
506
0
3,500
0
0
0
0
0
0
730
515
175
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,946
3,902
7,960
14,010
23,062
19,131
31,766
28,701
22,167
22,224
25,680
31,446
19,854
13,823
8,809
0
27,999
26,181
20,573
27,024
26,848
28,125
27,748
27,776
27,798
26,284
15,058
0
51,987
52,334
41,752
30,338
15,876
47,525
48,636
66,082
59,374
78,241
47,896
78,257
124,575
124,57578,25747,89678,24159,37466,08248,63647,52515,87630,33841,75252,33451,987015,05826,28427,79827,77627,74828,12526,84827,02420,57326,18127,99908,80913,82319,85431,44625,68022,22422,16728,70131,76619,13123,06214,0107,9603,9024,946000000000000000001755157300000003,50005065065091,0081,0101,5063,5214,51400361352319000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
100
300
400
300
400
300
300
319
822
1,038
193
193
193
0
0
0
502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
244
244
0
0
0
0
0
0
0
0
0
0
27
11
75
54
86
90
190
159
186
164
134
108
84
23
43
0
108
79
87
80
95
95
0
0
0
0
0
0
0
771
931
1,384
1,389
903
88
0
0
8,623
17,484
39,320
51,093
51,09339,32017,4848,62300889031,3891,3849317710000000959580877910804323841081341641861591909086547511270000000000244244000000000000002500000000000000000005020001931931931,038822319300300400300400300100000000000
       Other Current Assets 
0
0
100
0
100
100
0
0
100
100
100
100
0
0
0
0
38
38
38
23
23
10
27
39
39
5
82
59
59
34
27
25
14
27
23
40
0
17
20
195
62
976
749
265
265
353
202
216
234
136
75
768
567
55
87
246
120
158
147
142
66
117
101
87
79
89
65
29
225
137
118
48
360
198
259
174
702
549
458
308
731
650
501
216
1,058
928
796
437
978
816
526
439
1,464
987
864
611
1,944
1,536
641
1,083
4,804
2,950
2,502
2,884
4,020
3,136
2,954
6,596
45,073
15,951
17,082
9,519
9,51917,08215,95145,0736,5962,9543,1364,0202,8842,5022,9504,8041,0836411,5361,9446118649871,4644395268169784377969281,058216501650731308458549702174259198360481181372252965897987101117661421471581202468755567768751362342162023532652657499766219520170402327142527345959825393927102323383838000010010010010000100100010000
   > Long-term Assets 
0
100
200
100
100
100
300
300
300
300
300
200
200
200
200
200
375
211
312
297
297
190
148
0
128
106
90
0
76
3,092
81
8
40
55
194
190
325
186
175
177
171
161
149
0
154
133
123
115
121
261
94
375
764
615
442
102
17,796
17,767
17,767
17,766
17,752
17,752
17,751
6,072
6,072
6,073
6,073
3,598
3,598
3,690
3,686
5,809
1,886
7,015
878
1,532
1,531
19,878
22,677
26,600
29,486
25,246
4,355
3,917
4,293
4,153
4,120
4,064
4,036
4,677
4,637
4,585
12,480
12,144
12,972
13,863
13,833
13,683
13,521
13,902
13,686
26,332
37,908
48,664
60,812
49,106
34,969
25,298
12,575
12,280
11,953
11,644
11,64411,95312,28012,57525,29834,96949,10660,81248,66437,90826,33213,68613,90213,52113,68313,83313,86312,97212,14412,4804,5854,6374,6774,0364,0644,1204,1534,2933,9174,35525,24629,48626,60022,67719,8781,5311,5328787,0151,8865,8093,6863,6903,5983,5986,0736,0736,0726,07217,75117,75217,75217,76617,76717,76717,79610244261576437594261121115123133154014916117117717518632519019455408813,0927609010612801481902972973122113752002002002002003003003003003001001001002001000
       Property Plant Equipment 
0
100
100
100
100
200
200
300
300
300
300
300
200
200
200
100
122
122
218
227
227
121
116
105
105
84
70
56
56
10
10
8
40
55
124
119
126
116
104
107
101
90
78
83
84
63
52
45
37
35
12
9
7
6
5
4
3
4
4
3
2
2
2
0
0
1
1
1
1
3
4
6
8
7
8
20
25
35
69
47
323
2,303
2,845
2,370
2,799
2,769
2,735
2,677
2,649
2,641
2,599
2,545
10,437
10,099
10,925
11,813
11,782
11,629
11,465
11,844
11,627
11,515
11,296
11,068
11,276
10,963
11,135
10,822
8,689
8,475
8,271
8,145
8,1458,2718,4758,68910,82211,13510,96311,27611,06811,29611,51511,62711,84411,46511,62911,78211,81310,92510,09910,4372,5452,5992,6412,6492,6772,7352,7692,7992,3702,8452,303323476935252087864311110022234434567912353745526384837890101107104116126119124554081010565670841051051161212272272181221221002002002003003003003003002002001001001001000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
630
630
630
630
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799
799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799799630630630630000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,919
0
6,110
0
0
0
18,311
21,088
25,003
26,458
21,435
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,757
24,550
35,533
47,472
36,078
21,766
12,404
0
0
0
0
000012,40421,76636,07847,47235,53324,55012,757000000000000000000021,43526,45825,00321,08818,3110006,11004,91900000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,141
3,062
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,742
17,743
17,742
17,743
17,742
17,742
17,742
5,442
5,442
5,442
5,442
2,798
2,798
2,798
2,798
799
799
799
799
800
799
799
799
799
799
799
799
800
799
800
800
800
799
799
799
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000007997997998008008007998007997997997997997997998007997997997992,7982,7982,7982,7985,4425,4425,4425,44217,74217,74217,74217,74317,74217,74317,742000000000000000000000000003,0623,1410000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
-200
0
0
0
253
89
94
71
86
69
31
23
23
22
20
20
3,161
3,082
71
0
0
0
71
71
199
71
70
70
71
71
71
71
71
71
71
70
83
226
82
366
757
609
438
98
17,793
17,764
17,763
17,764
17,750
17,750
17,749
6,071
6,071
6,072
6,072
3,597
3,597
3,686
3,682
5,803
1,878
7,008
870
1,512
1,506
19,843
22,608
26,553
29,163
24,913
4,027
3,590
3,984
3,865
3,852
3,817
2,985
3,613
3,570
3,535
1,244
3,449
3,405
3,380
3,420
3,412
3,361
13,103
3,258
3,206
409,687
48,664
3,051
2,999
2,949
2,900
-1,593,698
63,669
89,955
329,587
329,58789,95563,669-1,593,6982,9002,9492,9993,05148,664409,6873,2063,25813,1033,3613,4123,4203,3803,4053,4491,2443,5353,5703,6132,9853,8173,8523,8653,9843,5904,02724,91329,16326,55322,60819,8431,5061,5128707,0081,8785,8033,6823,6863,5973,5976,0726,0726,0716,07117,74917,75017,75017,76417,76317,76417,79398438609757366822268370717171717171717070711997171000713,0823,1612020222323316986719489253000-200000000000000
> Total Liabilities 
0
400
400
300
300
300
300
400
200
600
600
600
300
400
200
600
496
542
1,062
2,080
2,080
707
748
509
509
428
504
578
578
1,054
1,266
966
758
624
1,475
1,196
1,271
1,775
1,809
1,666
2,247
2,215
1,414
1,943
1,943
2,530
1,791
1,872
1,786
4,420
4,963
5,625
6,565
7,446
7,327
7,151
27,599
25,376
24,770
24,000
19,957
20,511
18,359
6,271
5,887
6,744
7,338
6,524
6,688
17,859
9,662
48,112
3,742
56,302
77,544
86,747
117,269
10,656
11,095
113,473
10,617
16,096
75,687
54,782
123,256
23,223
22,236
97,382
35,762
140,715
42,630
59,580
98,284
93,380
119,118
124,399
103,202
100,394
103,198
106,292
103,414
98,270
98,170
142,476
132,642
122,631
117,410
134,985
169,925
180,401
166,298
169,085
169,085166,298180,401169,925134,985117,410122,631132,642142,47698,17098,270103,414106,292103,198100,394103,202124,399119,11893,38098,28459,58042,630140,71535,76297,38222,23623,223123,25654,78275,68716,09610,617113,47311,09510,656117,26986,74777,54456,3023,74248,1129,66217,8596,6886,5247,3386,7445,8876,27118,35920,51119,95724,00024,77025,37627,5997,1517,3277,4466,5655,6254,9634,4201,7861,8721,7912,5301,9431,9431,4142,2152,2471,6661,8091,7751,2711,1961,4756247589661,2661,0545785785044285095097487072,0802,0801,0625424966002004003006006006002004003003003003004004000
   > Total Current Liabilities 
0
400
300
300
300
400
300
400
200
600
600
700
600
400
200
500
496
542
1,062
2,080
2,080
707
748
509
509
428
504
578
578
1,054
1,266
966
758
624
1,475
1,196
1,271
1,451
1,809
1,666
2,247
2,215
1,414
1,943
1,943
2,530
1,791
1,872
1,786
1,467
2,014
1,486
993
1,797
1,598
2,532
7,203
4,928
4,208
3,293
3,352
3,783
1,515
1,606
1,222
2,349
2,958
2,216
2,473
3,466
5,678
6,317
1,989
2,606
8,902
5,121
9,553
9,208
9,686
10,528
8,894
14,119
16,881
16,878
19,727
20,759
19,790
27,957
33,345
36,938
40,242
38,854
60,940
55,967
80,197
84,449
63,118
67,537
77,670
87,554
92,494
87,551
87,655
65,384
54,656
43,326
36,447
53,201
63,076
72,667
57,678
53,720
53,72057,67872,66763,07653,20136,44743,32654,65665,38487,65587,55192,49487,55477,67067,53763,11884,44980,19755,96760,94038,85440,24236,93833,34527,95719,79020,75919,72716,87816,88114,1198,89410,5289,6869,2089,5535,1218,9022,6061,9896,3175,6783,4662,4732,2162,9582,3491,2221,6061,5153,7833,3523,2934,2084,9287,2032,5321,5981,7979931,4862,0141,4671,7861,8721,7912,5301,9431,9431,4142,2152,2471,6661,8091,4511,2711,1961,4756247589661,2661,0545785785044285095097487072,0802,0801,0625424965002004006007006006002004003004003003003004000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70
70
70
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70
70
70
0
0
1,274
1,989
2,013
2,037
2,054
2,310
775
761
878
678
678
678
678
678
678
678
678
678
159
183
275
272
295
182
212
153
91
117
69
175
153
182
128
224
210
91
67
1,261
1,283
1,365
1,616
1,602
8,855
16,204
23,848
31,660
24,658
17,467
2,412
1,492
1,480
1,616
1,581
1,546
1,512
1,479
1,446
1,4461,4791,5121,5461,5811,6161,4801,4922,41217,46724,65831,66023,84816,2048,8551,6021,6161,3651,2831,261679121022412818215317569117911532121822952722751831596786786786786786786786786788787617752,3102,0542,0372,0131,9891,2740070707000000000000000000007070700000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
275
0
0
0
212
153
91
117
69
175
153
182
128
224
210
91
67
133
145
95
190
0
7,200
14,590
22,179
30,127
23,158
15,999
975
0
0
0
0
0
0
0
0
0000000097515,99923,15830,12722,17914,5907,20001909514513367912102241281821531756911791153212000275000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
496
542
1,062
785
786
707
748
509
509
428
504
578
578
574
761
549
569
414
1,387
1,144
1,112
1,303
1,714
1,617
1,991
1,963
1,086
1,393
1,393
1,002
852
1,279
986
617
705
542
144
173
143
215
303
374
396
224
183
208
168
667
468
322
1,799
1,117
1,388
2,248
4,325
4,765
1,639
1,899
7,968
3,992
8,880
8,254
8,583
9,346
8,139
13,080
15,550
15,268
18,916
20,454
18,180
25,877
32,513
35,394
37,917
38,635
40,199
33,206
33,997
33,077
31,547
29,670
34,659
37,014
45,803
48,209
57,065
61,003
-419
37,224
29,726
42,019
57,092
62,945
39,741
38,471
38,47139,74162,94557,09242,01929,72637,224-41961,00357,06548,20945,80337,01434,65929,67031,54733,07733,99733,20640,19938,63537,91735,39432,51325,87718,18020,45418,91615,26815,55013,0808,1399,3468,5838,2548,8803,9927,9681,8991,6394,7654,3252,2481,3881,1171,7993224686671682081832243963743032151431731445427056179861,2798521,0021,3931,3931,0861,9631,9911,6171,7141,3031,1121,1441,3874145695497615745785785044285095097487077867851,062542496500000000000000000
       Other Current Liabilities 
0
400
300
300
300
400
300
400
200
600
600
700
600
400
200
0
0
0
0
1,295
1,295
1,295
0
0
0
0
0
0
520
410
435
417
188
211
88
52
158
148
95
48
256
252
329
550
550
1,528
939
592
800
850
1,238
874
849
1,624
1,455
785
4,621
2,190
1,360
535
293
2,640
539
438,080
77
1,350
480
269
255
389
523
723
197
396
599
702
248
506
769
818
449
796
1,062
1,390
484
20,454
1,275
1,800
456
1,182
2,082
38,635
18,626
54,684
44,035
48,994
29,245
28,326
26,159
26,082
14,460
14,151
12,628
1,512
53,164
4,241
4,762
9,296
4,171
7,981
9,555
13,503
13,5039,5557,9814,1719,2964,7624,24153,1641,51212,62814,15114,46026,08226,15928,32629,24548,99444,03554,68418,62638,6352,0821,1824561,8001,27520,4544841,3901,0627964498187695062487025993961977235233892552694801,35077438,0805392,6402935351,3602,1904,6217851,4551,6248498741,2388508005929391,528550550329252256489514815852882111884174354105200000001,2951,2951,29500002004006007006006002004003004003003003004000
   > Long-term Liabilities 
0
0
100
0
0
-100
0
0
0
0
0
-100
-300
0
0
100
496
542
1,062
0
786
707
748
0
509
428
504
0
578
644
831
549
569
414
1,387
1,144
1,112
324
1,714
1,617
1,991
1,963
1,086
0
1,393
1,002
852
1,279
2,000
2,953
2,949
4,139
5,572
5,649
5,728
4,618
20,396
20,448
20,562
20,706
16,605
16,728
16,844
4,665
4,665
4,395
4,380
4,308
4,215
4,117
3,983
1,741
1,754
1,600
1,562
1,524
1,486
1,448
1,410
1,371
1,723
1,977
2,051
2,035
2,488
2,464
2,446
2,431
2,417
2,401
2,388
20,726
37,344
37,413
38,921
39,950
40,084
32,857
25,528
18,738
10,920
10,719
10,515
77,092
77,986
79,305
80,963
81,784
106,849
107,734
108,620
115,365
115,365108,620107,734106,84981,78480,96379,30577,98677,09210,51510,71910,92018,73825,52832,85740,08439,95038,92137,41337,34420,7262,3882,4012,4172,4312,4462,4642,4882,0352,0511,9771,7231,3711,4101,4481,4861,5241,5621,6001,7541,7413,9834,1174,2154,3084,3804,3954,6654,66516,84416,72816,60520,70620,56220,44820,3964,6185,7285,6495,5724,1392,9492,9532,0001,2798521,0021,39301,0861,9631,9911,6171,7143241,1121,1441,3874145695498316445780504428509074870778601,06254249610000-300-10000000-1000010000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,475
16,389
4,007
4,665
4,395
4,380
2,479
2,424
2,365
2,269
65
116
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,286
28,513
28,741
28,970
29,201
22,233
15,074
7,716
0
0
0
66,788
67,249
68,947
70,038
71,135
96,503
97,700
0
0
0097,70096,50371,13570,03868,94767,24966,7880007,71615,07422,23329,20128,97028,74128,51328,2860000000000000000000116652,2692,3652,4242,4794,3804,3954,6654,00716,38916,4750000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,953
2,949
4,124
4,012
4,066
4,121
4,005
4,017
4,189
4,382
4,576
50
252
455
658
0
0
0
1,829
1,791
1,752
1,714
1,676
1,638
1,600
1,562
1,524
1,485
1,447
1,409
1,372
1,723
1,978
2,051
2,036
2,487
2,464
2,446
2,432
2,417
2,401
2,388
20,726
876
838
800
762
724
686
648
610
571
533
495
457
419
381
343
305
0
0
0
0
000030534338141945749553357161064868672476280083887620,7262,3882,4012,4172,4322,4462,4642,4872,0362,0511,9781,7231,3721,4091,4471,4851,5241,5621,6001,6381,6761,7141,7521,7911,829000658455252504,5764,3824,1894,0174,0054,1214,0664,0124,1242,9492,9530000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,829
1,790
1,752
1,714
1,676
1,638
1,600
1,562
1,524
1,486
1,448
1,410
1,371
1,723
1,977
2,051
2,035
2,488
2,464
2,446
2,431
2,417
2,401
2,388
2,376
876
838
800
762
724
686
648
610
571
1,945
495
457
419
381
343
305
267
229
0
0
002292673053433814194574951,9455716106486867247628008388762,3762,3882,4012,4172,4312,4462,4642,4882,0352,0511,9771,7231,3711,4101,4481,4861,5241,5621,6001,6381,6761,7141,7521,7901,8290000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
2,500
3,100
2,100
1,300
2,200
9,900
8,400
7,200
8,200
7,100
5,900
5,000
4,300
4,000
3,400
3,351
2,134
2,026
1,097
496
523
-133
1,249
1,250
630
44
0
-327
2,550
-736
6,833
9,200
8,323
6,151
4,454
3,121
824
11,265
9,540
7,028
5,473
3,902
1,505
1,505
2,746
567
-891
-299
-3,447
-4,758
-4,376
-5,003
-6,307
-6,644
-6,785
-7,518
-5,782
-5,735
-5,364
-1,303
-2,150
-295
9,625
11,738
11,016
9,372
15,550
14,699
10,275
44,638
40,054
54,432
52,096
67,080
80,102
106,231
112,950
116,312
101,573
89,446
78,701
56,755
35,868
101,042
77,975
79,546
66,993
85,232
101,376
71,744
24,036
19,254
13,205
-661,643
-701,216
-1,353
194,227
170,658
519,350
445,285
-1,149,722
-1,235,359
-1,328,698
170,386
-1,438,221
100,481
-1,527,033
-1,566,265
-1,613,875
-1,499,945
160,502
160,502-1,499,945-1,613,875-1,566,265-1,527,033100,481-1,438,221170,386-1,328,698-1,235,359-1,149,722445,285519,350170,658194,227-1,353-701,216-661,64313,20519,25424,03671,744101,37685,23266,99379,54677,975101,04235,86856,75578,70189,446101,573116,312112,950106,23180,10267,08052,09654,43240,05444,63810,27514,69915,5509,37211,01611,7389,625-295-2,150-1,303-5,364-5,735-5,782-7,518-6,785-6,644-6,307-5,003-4,376-4,758-3,447-299-8915672,7461,5051,5053,9025,4737,0289,54011,2658243,1214,4546,1518,3239,2006,833-7362,550-3270446301,2501,249-1335234961,0972,0262,1343,3513,4004,0004,3005,0005,9007,1008,2007,2008,4009,9002,2001,3002,1003,1002,5000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
5
6
6
6
6
7
7
16
16
17
17
17
17
117
23
23
27
27
27
28
30
41
59
60
60
60
60
60
60
70
71
71
71
71
71
71
71
71
71
71
114
121
121
121
130
3
7
285
5
18
20
26
26
27
33
34
38
38
41
45
47
52
53
54
54
54
55
57
67
68
71
73
77
82
83
84
89
93
97
109
110
127
129
141
142
143
143
143
145
145
145
146
149
151
151
151
15115115114914614514514514314314314214112912711010997938984838277737168675755545454535247454138383433272626201852857313012112112111471717171717171717171706060606060605941302827272723231171717171716167766665500000000000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-60,460
61,012
-853
-11,109
-13,004
-15,466
-18,926
-22,599
-29,184
-33,740
-39,404
-46,951
-58,938
-76,389
-95,185
-109,763
-126,866
-140,522
-158,134
-171,983
-187,882
-212,713
-236,387
-264,114
-292,467
-324,003
-354,863
-396,392
-440,534
-474,485
-528,345
-563,501
599,713
-661,643
-701,216
-752,332
-805,215
-892,379
-980,597
-1,071,225
-1,149,722
-1,235,359
-1,328,698
-1,397,711
-1,438,221
-1,474,039
-1,527,033
-1,566,265
-1,613,875
0
0
00-1,613,875-1,566,265-1,527,033-1,474,039-1,438,221-1,397,711-1,328,698-1,235,359-1,149,722-1,071,225-980,597-892,379-805,215-752,332-701,216-661,643599,713-563,501-528,345-474,485-440,534-396,392-354,863-324,003-292,467-264,114-236,387-212,713-187,882-171,983-158,134-140,522-126,866-109,763-95,185-76,389-58,938-46,951-39,404-33,740-29,184-22,599-18,926-15,466-13,004-11,109-85361,012-60,4600000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-100
-100
-100
-100
-100
-200
-200
-200
-300
-300
-300
-400
-400
-200
0
0
0
-297
0
0
0
-49
0
0
0
-77
-77
-8
-41
-8
102
297
162
296
201
-13
154
1
2
-1
-1
-160
-160
-160
-53,000
-181
-181
-181
-181
-27
-27
0
0
-32
-32
0
-62,000
-36
-36
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000-36-36-62,0000-32-3200-27-27-181-181-181-181-53,000-160-160-160-1-121154-13201296162297102-8-41-8-77-77000-49000-297000-200-400-400-300-300-300-200-200-200-100-100-100-100-10000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,292
60,694
10,177
22,841
24,001
24,818
34,535
37,357
39,517
78,429
79,658
101,580
111,230
143,662
175,477
216,180
239,999
257,016
259,887
261,609
266,763
269,647
272,432
365,324
370,609
403,712
422,017
481,781
542,062
546,380
552,531
582,900
613,059
635,989
739,956
751,103
999,549
1,063,142
1,500,040
1,516,602
1,532,943
1,546,967
1,565,942
1,568,186
1,567,345
1,574,609
1,585,708
1,593,783
1,654,411
0
0
001,654,4111,593,7831,585,7081,574,6091,567,3451,568,1861,565,9421,546,9671,532,9431,516,6021,500,0401,063,142999,549751,103739,956635,989613,059582,900552,531546,380542,062481,781422,017403,712370,609365,324272,432269,647266,763261,609259,887257,016239,999216,180175,477143,662111,230101,58079,65878,42939,51737,35734,53524,81824,00122,84110,17760,69458,2920000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-234-85-85-85-850000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
8,900
10,700
10,600
10,800
13,600
22,100
22,100
22,300
21,700
22,000
22,500
22,500
22,100
22,100
21,900
22,974
24,864
25,727
0
24,796
25,423
25,503
0
27,442
27,411
27,411
0
27,488
4,733
4,826
14,290
17,851
17,822
18,080
18,083
18,398
29,789
41,933
42,751
43,053
43,355
43,682
0
44,572
53,262
106,591
54,219
56,370
54,665
54,748
54,848
54,829
54,917
54,995
55,110
55,935
55,813
117,819
55,860
56,044
58,308
60,710
10,192
22,841
24,001
24,818
34,450
37,272
39,432
78,344
79,424
101,345
110,995
143,428
175,242
215,946
239,764
256,781
259,653
261,374
266,528
269,413
272,198
365,089
370,374
403,478
421,783
481,547
541,828
546,146
552,297
582,666
612,825
-97
-109
750,869
999,315
1,062,908
1,499,806
1,516,368
-143
-143
-143
1,567,952
-145
1,574,375
-146
-149
-151
-151
1,674,712
1,674,712-151-151-149-1461,574,375-1451,567,952-143-143-1431,516,3681,499,8061,062,908999,315750,869-109-97612,825582,666552,297546,146541,828481,547421,783403,478370,374365,089272,198269,413266,528261,374259,653256,781239,764215,946175,242143,428110,995101,34579,42478,34439,43237,27234,45024,81824,00122,84110,19260,71058,30856,04455,860117,81955,81355,93555,11054,99554,91754,82954,84854,74854,66556,37054,219106,59153,26244,572043,68243,35543,05342,75141,93329,78918,39818,08318,08017,82217,85114,2904,8264,73327,488027,41127,41127,442025,50325,42324,796025,72724,86422,97421,90022,10022,10022,50022,50022,00021,70022,30022,10022,10013,60010,80010,60010,7008,9000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue233,662
Cost of Revenue-14,554
Gross Profit219,108219,108
 
Operating Income (+$)
Gross Profit219,108
Operating Expense-198,475
Operating Income20,63320,633
 
Operating Expense (+$)
Research Development76,192
Selling General Administrative135,716
Selling And Marketing Expenses13,433
Operating Expense198,475225,341
 
Net Interest Income (+$)
Interest Income0
Interest Expense-12,615
Other Finance Cost-0
Net Interest Income-12,615
 
Pretax Income (+$)
Operating Income20,633
Net Interest Income-12,615
Other Non-Operating Income Expenses0
Income Before Tax (EBT)13,06228,204
EBIT - interestExpense = 8,018
13,062
25,287
Interest Expense12,615
Earnings Before Interest and Taxes (EBIT)20,63325,677
Earnings Before Interest and Taxes (EBITDA)21,056
 
After tax Income (+$)
Income Before Tax13,062
Tax Provision-390
Net Income From Continuing Ops12,67212,672
Net Income12,672
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses213,029
Total Other Income/Expenses Net-7,57112,615
 

Technical Analysis of TG Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of TG Therapeutics Inc. The general trend of TG Therapeutics Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine TG Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TG Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 14.04 < 15.37 < 15.99.

The bearish price targets are: 12.84 > 11.80 > 11.56.

Tweet this
TG Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TG Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TG Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TG Therapeutics Inc. The current macd is -0.40655421.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the TG Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for TG Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the TG Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
TG Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartTG Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TG Therapeutics Inc. The current adx is 15.97.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell TG Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
TG Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TG Therapeutics Inc. The current sar is 15.24.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
TG Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TG Therapeutics Inc. The current rsi is 34.59. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
TG Therapeutics Inc Daily Relative Strength Index (RSI) ChartTG Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TG Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the TG Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
TG Therapeutics Inc Daily Stochastic Oscillator ChartTG Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TG Therapeutics Inc. The current cci is -141.85398706.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
TG Therapeutics Inc Daily Commodity Channel Index (CCI) ChartTG Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TG Therapeutics Inc. The current cmo is -44.98104395.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
TG Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartTG Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TG Therapeutics Inc. The current willr is -86.82926829.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
TG Therapeutics Inc Daily Williams %R ChartTG Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of TG Therapeutics Inc.

TG Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TG Therapeutics Inc. The current atr is 0.65895548.

TG Therapeutics Inc Daily Average True Range (ATR) ChartTG Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TG Therapeutics Inc. The current obv is 130,426,091.

TG Therapeutics Inc Daily On-Balance Volume (OBV) ChartTG Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TG Therapeutics Inc. The current mfi is 26.00.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
TG Therapeutics Inc Daily Money Flow Index (MFI) ChartTG Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TG Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

TG Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TG Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.594
Ma 20Greater thanMa 5014.814
Ma 50Greater thanMa 10015.157
Ma 100Greater thanMa 20015.681
OpenGreater thanClose14.060
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of TG Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on TG Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about TG Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TG Therapeutics Inc

I send you an email if I find something interesting about TG Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TG Therapeutics Inc.

Receive notifications about TG Therapeutics Inc in your mailbox!